Skip to main content

Moderna Tumbles On Report Of Delayed COVID Vaccine Trial

Moderna shares are down 7% following headlines that its virus vaccine trial has been delayed.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.